Skip to main content

Table 2 Comparison of ankle brachial index and cardiovascular risk factorsbetween the study and control group using student’s t-test and chi-square

From: Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: a cross sectional study

Parameter

Study group (n = 150)

Control group (n = 50)

P-value

ABI

0.92 ± 0.08

0.94 ± 0.05

0.175

Normal 1.0–1.3 (%)

42 (27.8)

16 (10.6)

0.589

Borderline 0.9–0.99 (%)

86 (57.0)

31 (20.5)

0.562

PAD < 0.90 (%)

22 (14.6)

3 (2.0)

0.108

TC (mmol/L)

4.65 ± 0.68

4.61 ± 0.98

0.453

TG (mmol/L)

2.27 ± 0.21

2.20 ± 0.14

0.001*

HDL-C (mmol/L)

1.12 ± 0.08

1.19 ± 0.07

0.001*

LDL-C (mmol/L)

2.51 ± 0.70

2.42 ± 0.94

0.236

FPG (mmol/L)

4.51 ± 0.80

4.14 ± 0.68

0.001*

Family history of CVD (%)

13 (8.6)

20 (13.2)

0.355

Diabetes (%)

6 (4.0)

1 (2.0)

0.505

Hypertension (%)

24 (15.9)

5 (3.3)

0.297

Metabolic syndrome (%)

26 (17.3)

5 (10.0)

0.215

  1. Data are presented as mean ± standard deviation or numbers (percentages). * = significant at P < 0.05. PAD Peripheral artery disease, ABI Ankle brachial index, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, WC Waist circumference, WHR Waist to hip ratio, CVD Cardiovascular disease, TC Total cholesterol, TG triglyceride, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, FPG Fasting plasma glucose